Aethlon Medical (AEMD) Current Deferred Revenue (2019 - 2022)

Aethlon Medical's Current Deferred Revenue history runs 4 years deep, the most recent figure standing at $574245.0 for Q4 2022.

• For the quarter ending Q4 2022, Current Deferred Revenue rose 150.0% year-over-year to $574245.0; the trailing twelve-month figure through Dec 2022 stood at $574245.0 (up 150.0% YoY), and the FY2022 full-year result was $344547.0, up 200.0% from the prior year.
• Current Deferred Revenue was $574245.0 for Q4 2022 at Aethlon Medical, roughly flat from $574245.0 in the prior quarter.
• Over the last five years, Current Deferred Revenue for AEMD reached as high as $574245.0 in Q3 2022 and fell as low as $100000.0 in Q3 2019.
• Median Current Deferred Revenue over the past 4 years was $229698.0 (2021), compared with a mean of $280033.0.
• Across the five-year window, Current Deferred Revenue surged 407.02% in 2020 and tumbled 77.35% in 2021, its largest moves.
• Over 4 years, Current Deferred Revenue stood at $100000.0 in 2019, then surged by 407.02% to $507022.0 in 2020, then slumped by 54.7% to $229698.0 in 2021, then soared by 150.0% to $574245.0 in 2022.
• Business Quant data shows AEMD's Current Deferred Revenue at $574245.0 in Q4 2022, $574245.0 in Q3 2022, and $459396.0 in Q2 2022.